Mankin H - Search Results

1

Multidrug resistant osteosarcoma cell lines exhibit deficiency of GADD45alpha expression.

Yang C, Yang S, Wood KB, Hornicek FJ, Schwab JH, Fondren G, Mankin H, Duan Z. Yang C, et al. Among authors: mankin h. Apoptosis. 2009 Jan;14(1):124-33. doi: 10.1007/s10495-008-0282-x. Apoptosis. 2009. PMID: 19052873

2

RAIDD expression is impaired in multidrug resistant osteosarcoma cell lines.

Yang C, Hornicek FJ, Wood KB, Schwab JH, Mankin H, Duan Z. Yang C, et al. Among authors: mankin h. Cancer Chemother Pharmacol. 2009 Aug;64(3):607-14. doi: 10.1007/s00280-008-0912-6. Epub 2009 Jan 6. Cancer Chemother Pharmacol. 2009. PMID: 19125251

3

Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines.

Duan Z, Choy E, Harmon D, Yang C, Ryu K, Schwab J, Mankin H, Hornicek FJ. Duan Z, et al. Among authors: mankin h. Mol Cancer Ther. 2009 Aug;8(8):2122-30. doi: 10.1158/1535-7163.MCT-09-0115. Epub 2009 Jul 28. Mol Cancer Ther. 2009. PMID: 19638450 Free PMC article.

4

ZNF93 increases resistance to ET-743 (Trabectedin; Yondelis) and PM00104 (Zalypsis) in human cancer cell lines.

Duan Z, Choy E, Harmon D, Yang C, Ryu K, Schwab J, Mankin H, Hornicek FJ. Duan Z, et al. Among authors: mankin h. PLoS One. 2009 Sep 9;4(9):e6967. doi: 10.1371/journal.pone.0006967. PLoS One. 2009. PMID: 19742314 Free PMC article.

5

Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcoma.

Susa M, Iyer AK, Ryu K, Hornicek FJ, Mankin H, Amiji MM, Duan Z. Susa M, et al. Among authors: mankin h. BMC Cancer. 2009 Nov 16;9:399. doi: 10.1186/1471-2407-9-399. BMC Cancer. 2009. PMID: 19917123 Free PMC article.

6

The kinase Mirk is a potential therapeutic target in osteosarcoma.

Yang C, Ji D, Weinstein EJ, Choy E, Hornicek FJ, Wood KB, Liu X, Mankin H, Duan Z. Yang C, et al. Among authors: mankin h. Carcinogenesis. 2010 Apr;31(4):552-8. doi: 10.1093/carcin/bgp330. Epub 2009 Dec 30. Carcinogenesis. 2010. PMID: 20042639 Free PMC article.

7

Lentiviral shRNA screen of human kinases identifies PLK1 as a potential therapeutic target for osteosarcoma.

Duan Z, Ji D, Weinstein EJ, Liu X, Susa M, Choy E, Yang C, Mankin H, Hornicek FJ. Duan Z, et al. Among authors: mankin h. Cancer Lett. 2010 Jul 28;293(2):220-9. doi: 10.1016/j.canlet.2010.01.014. Epub 2010 Feb 9. Cancer Lett. 2010. PMID: 20144850

8

Multidrug resistance reversal agent, NSC77037, identified with a cell-based screening assay.

Susa M, Choy E, Yang C, Schwab J, Mankin H, Hornicek F, Duan Z. Susa M, et al. Among authors: mankin h. J Biomol Screen. 2010 Mar;15(3):287-96. doi: 10.1177/1087057109359422. Epub 2010 Feb 11. J Biomol Screen. 2010. PMID: 20150589

9

Characterization and analysis of human chordoma cell lines.

Yang C, Hornicek FJ, Wood KB, Schwab JH, Choy E, Iafrate J, Rosenberg A, Nielsen GP, Xavier RJ, Mankin H, Duan Z. Yang C, et al. Among authors: mankin h. Spine (Phila Pa 1976). 2010 Jun 1;35(13):1257-64. doi: 10.1097/BRS.0b013e3181c2a8b0. Spine (Phila Pa 1976). 2010. PMID: 20461036 Free PMC article.

10

Histone deacetylase inhibitor (HDACI) PCI-24781 potentiates cytotoxic effects of doxorubicin in bone sarcoma cells.

Yang C, Choy E, Hornicek FJ, Wood KB, Schwab JH, Liu X, Mankin H, Duan Z. Yang C, et al. Among authors: mankin h. Cancer Chemother Pharmacol. 2011 Feb;67(2):439-46. doi: 10.1007/s00280-010-1344-7. Epub 2010 May 12. Cancer Chemother Pharmacol. 2011. PMID: 20461381

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

551 results

Search Page